{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:51:27Z","timestamp":1792097487908,"version":"4.4.0"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Molecular Genetics"],"DOI":"10.1093\/hmg\/ddg256","type":"journal-article","created":{"date-parts":[[2003,9,15]],"date-time":"2003-09-15T16:02:15Z","timestamp":1063641735000},"page":"2481-2489","source":"Crossref","is-referenced-by-count":302,"title":["Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy"],"prefix":"10.1093","volume":"12","author":[{"given":"L.","family":"Brichta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2003,8,5]]},"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/12\/19\/2481\/6948222\/ddg256.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T06:43:13Z","timestamp":1503556993000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article-lookup\/doi\/10.1093\/hmg\/ddg256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8,5]]},"references-count":0,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2003,8,5]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddg256","relation":{},"ISSN":["1460-2083"],"issn-type":[{"value":"1460-2083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,8,5]]}}}